Hoth Therapeutics accepted into Nvidia Connect Program

Hoth Therapeutics (HOTH) has been officially accepted into the Nvidia (NVDA) Connect Program, a global initiative supporting innovative software and technology companies working with advanced computing and AI platforms. Acceptance into the NVIDIA Connect Program provides Hoth Therapeutics with access to a suite of accelerated computing resources, technical guidance, and marketing support. Through the NVIDIA Connect Program, Hoth Therapeutics will gain access to: NVIDIA GPU-accelerated developer tools to enhance computational-biology workflows, including target identification, protein-structure modeling, and preclinical data analytics. Technical expertise, SDKs, and APIs that can support algorithmic modeling across Hoth’s programs. Participation in the Connect Program is expected to streamline key aspects of Hoth’s R&D strategy, reducing computational bottlenecks and enhancing predictive modeling.